Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Postoperative Delirium in Temporal Glioma
NCT06164314Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jan 2024
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in postoperative delirium (POD) comparing Dex group with Placebo group (2 arms). Primary endpoint: Incidence of postoperative delirium at 5 days. Started Jan 2024; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT06164314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06164314.